Aller au contenu principal
Accès ouvert déclaré 2025 article

The effect of enhancers on the lentiviral transduction efficiency in the human RPE cells: Insights for advancing retinal gene therapies

1Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : ir. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Background: Viral vectors including lentiviruses (LV), adenoviruses (AV) and adeno-associated viruses (AAV) have been used as common vehicles for gene transfer in gene therapy of various human diseases. The efficacy of gene transfer, however, still remains unsatisfying and thus, a number of biologic and chemical substances are used for enhancing the transduction efficiency. In this article, we aim to evaluate the cytotoxicity and impact of individual and combinational treatment of two polycationic agents hexadimethrine bromide (polybrene; Pb) and protamine sulfate (PS) on the transduction efficiency of lentiviral particles in the primary human retinal pigment epithelial (RPE) cells. Methods: Cytotoxicity of Pb and PS at individual and combinational concentrations was evaluated using MTT cell viability assay in RPE cells. Lentiviral particles were produced using a set of second-generation vectors and different combinations of two enhancers, Pb and PS, were added to the transduction medium. The transduction efficiency of lentiviral particles in RPE cells was evaluated using flow cytometry and calculating the mean fluorescence intensity (MFI), as well as the percentage of green fluorescent protein (GFP)-positive cells. All the treatments were performed in three replicates. Results: Cell viability assay revealed that individual treatment of Pb at all concentrations by up to 25 μg/ml was safe to RPE cells with no visible toxicity and its combination with PS did not significantly improve its effect on the cell viability. Interestingly, Pb at all concentrations significantly improved the transduction efficiency compared to control virus with the best MFI result seen at 10 μg/ml concentration. The mean population of GFP-positive cells was also most enhanced at that concentration (p-value: 0.006). At a combinational concentration of 10 μg/ml of Pb and 2 μg/ml of PS, the highest level of transduction efficiency was reported (MFI: 801, GFP+: 65.4 %); however, the value was not significant when compared to enhancers used in individual treatments or relative to other combinations. Conclusion: Pb enhanced the transduction efficiency of lentiviral particles in RPE cells and in combination with PS achieved the highest level of MFI and GFP-positive percentage. Although, the efficiency of the combination was not significant compared to that of individual treatments, this study may suggest the potential of combinational enhancers for applications in gene therapy.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
The effect of enhancers on the lentiviral transduction efficiency in the human RPE cells: Insights for advancing retinal gene therapies
Date Crossref
01/06/2025
Éditeur
Elsevier BV
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Shahid Beheshti University of Medical Sciences Cellular and Molecular Biology Research Center pays non établi dans la notice
    Université ou école supérieure
  • School of Advanced Technologies in Medicine Department of Medical Biotechnology pays non établi dans la notice
    Université ou école supérieure

Cellular and Molecular Biology Research Center — Shahid Beheshti University of Medical Sciences et Department of Medical Biotechnology — School of Advanced Technologies in Medicine.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Virus-based gene therapy researchRetinal Development and DisordersCRISPR and Genetic Engineering

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.